Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2006 1
2009 2
2013 1
2014 1
2019 1
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
Zhou Y, Yan T, Zhou X, Cao P, Luo C, Zhou L, Xu Y, Liu Y, Xue J, Wang J, Wang Y, Lu Y, Liang B, Gong Y. Zhou Y, et al. Strahlenther Onkol. 2020 Jun;196(6):505-514. doi: 10.1007/s00066-019-01552-4. Epub 2019 Dec 11. Strahlenther Onkol. 2020. PMID: 31828393
PURPOSE: Severe acute radiation pneumonitis (SARP) is a life-threatening complication of thoracic radiotherapy. Pre-treatment pulmonary function (PF) may influence its incidence. We have previously reported on the incidence of SARP among patients with moderate pu …
PURPOSE: Severe acute radiation pneumonitis (SARP) is a life-threatening complication of thoracic radiotherapy. Pre-treatment pulmonary …
Impact and safety of adjuvant chemotherapy on pulmonary function in early stage non-small cell lung cancer.
Kreuter M, Vansteenkiste J, Herth FJ, Fischer JR, Eberhardt W, Zuna I, Reinmuth N, Griesinger F, Thomas M; TREAT investigators. Kreuter M, et al. Respiration. 2014;87(3):204-10. doi: 10.1159/000355361. Epub 2013 Oct 30. Respiration. 2014. PMID: 24192055 Free article. Clinical Trial.
BACKGROUND: Pulmonary function may decline after induction chemotherapy and predict perioperative complications in non-small cell lung cancer (NSCLC). ...Pulmonary function tests (forced expiratory volume in 1 …
BACKGROUND: Pulmonary function may decline after induction chemotherapy and predict perioperative complications in n …
Practical implications to contemplate when considering radical therapy for stage III non-small-cell lung cancer.
Storey CL, Hanna GG, Greystoke A; AstraZeneca UK Limited. Storey CL, et al. Br J Cancer. 2020 Dec;123(Suppl 1):28-35. doi: 10.1038/s41416-020-01072-4. Br J Cancer. 2020. PMID: 33293673 Free PMC article. Review.
The type of patients with stage III non-small-cell lung cancer (NSCLC) selected for concurrent chemoradiotherapy (cCRT) varies between and within countries, with higher-volume centres treating patients with more co-morbidities and higher-stage disease. …
The type of patients with stage III non-small-cell lung cancer (NSCLC) selected for concurrent chemoradiotherapy …
Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer.
Rivera MP, Detterbeck FC, Socinski MA, Moore DT, Edelman MJ, Jahan TM, Ansari RH, Luketich JD, Peng G, Monberg M, Obasaju CK, Gralla RJ. Rivera MP, et al. Chest. 2009 Jun;135(6):1588-1595. doi: 10.1378/chest.08-1430. Epub 2009 Feb 2. Chest. 2009. PMID: 19188545 Clinical Trial.
In this report, pulmonary function test (PFT) results were analyzed from two similar randomized phase 2 trials that tested platinum and nonplatinum regimens preoperatively in patients with stage I or II non-small cell lung cancer ( …
In this report, pulmonary function test (PFT) results were analyzed from two similar randomized phase 2 trials that tested pla …
Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advanced non-small cell lung cancer: analysis of early and late pulmonary morbidity.
Robert F, Childs HA, Spencer SA, Redden DT, Hawkins MM. Robert F, et al. Semin Radiat Oncol. 1999 Apr;9(2 Suppl 1):136-47. Semin Radiat Oncol. 1999. PMID: 10210553 Clinical Trial.
Recent efforts to improve survival outcome in patients with locally advanced non-small cell lung cancer have focused on the use of chemoradiotherapy regimens containing vinblastine/cisplatin or etoposide/cisplatin. ...Based on the activity of pa …
Recent efforts to improve survival outcome in patients with locally advanced non-small cell lung cancer have foc …
The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Milman S, Kim AW, Warren WH, Liptay MJ, Miller C, Basu S, Faber LP. Milman S, et al. Ann Thorac Surg. 2009 Sep;88(3):945-50; discussion 950-1. doi: 10.1016/j.athoracsur.2009.05.084. Ann Thorac Surg. 2009. PMID: 19699925
BACKGROUND: Concurrent neoadjuvant chemoradiotherapy can potentially impact on the results of sleeve lobectomy. The purpose of this study was to examine this effect in terms of morbidity, mortality, and long-term survival in patients with non-small cell …
BACKGROUND: Concurrent neoadjuvant chemoradiotherapy can potentially impact on the results of sleeve lobectomy. The purpose of this s …
Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
Takeda S, Funakoshi Y, Kadota Y, Koma M, Maeda H, Kawamura S, Matsubara Y. Takeda S, et al. Ann Thorac Surg. 2006 Jul;82(1):232-6. doi: 10.1016/j.athoracsur.2006.01.045. Ann Thorac Surg. 2006. PMID: 16798220
However, the impact of induction therapy on the pulmonary toxicity and associated pulmonary complications has not been fully investigated in the setting of lung cancer surgery. ...Results of pulmonary function before and after indu …
However, the impact of induction therapy on the pulmonary toxicity and associated pulmonary complications has no …